ADARX Pharmaceuticals

formerly AdaRx

Providing hope for patients with intractable disease

San Diego, United States · Founded 2019 · $275.0M raised

Employees
51–200
Founded
2019
Business Model
B2B
Website
adarx.com
Total Funding
$275.0M
Last Round
$200.0M Series CAug 2023
Rounds
2

About

ADARx Pharmaceuticals is a clinical-stage biotechnology company developing next-generation RNA therapeutics for challenging diseases. Its proprietary technology is designed to create targeted medicines across therapeutic areas, while the company advances programs intended to address serious conditions with limited treatment options.

Summary

ADARX Pharmaceuticals is a Biotech company based in San Diego, United States, founded in 2019. It has raised $275.0M in total across 2 rounds, most recently a $200.0M Series C round in Aug 2023. Investors include Bain Capital Life Sciences, TCGX and BlackRock.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Series CSeries CAug 2023
$200.0M

Sign up to see all 2 rounds

Series B through Series C — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

ADARX Pharmaceuticals on Indexed.vc
<a href="https://indexed.vc/companies/adarx-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/adarx-pharmaceuticals" alt="ADARX Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>